Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference31 articles.
1. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies;Passweg;Bone Marrow Transplant,2019
2. Phelan R, Arora M, Chen M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2020. Available at: https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx. Accessed July 2, 2021.
3. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019;Duarte;Bone Marrow Transplant,2019
4. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts;McDonald;Ann Intern Med,2020
5. Long-term complications after hematopoietic cell transplantation;Majhail;Hematol Oncol Stem Cell Ther,2017